NHS National Generic Pharmaceuticals Transition 2021_2 - Pemetrexed Solution for Infusion - LSNE
The NHS Commissioning Board (operating under the name of NHS England) · Awarded
- Buyer
- The NHS Commissioning Board (operating under the name of NHS England)
- Status
- Awarded
- Country
- United Kingdom
- Region
- England
- Sector
- Manufacturing
- Reference
- FaT-ocds-h6vhtk-02a9fe
- Published
- 2021-07-14
Tender summary
NHS National Pharmaceuticals Transition 2021_2 - Pemetrexed solution for infusion LSNE region.Offer reference number: CM/PHG/21/5639/00Period of framework agreement: The total maximum duration of the framework agreement to be no more than 38 months (19 months plus options to extend (at the Authority's sole discretion) for up to a further 19 months)FIND A TENDER (FTS) Reference number: 2021/S 000-008845Potential periods of call-offs under the framework agreement: 24/06/2021 to 31/01/2023 (19 months) LSNE region.
This is a public summary of a procurement notice. Dates and status reflect the notice held by BidScout; check the full notice before bidding.
Full tender details have a three-minute guest preview for open opportunities. AI insights require registration.
Register for full access